Close Menu

NEW YORK (GenomeWeb) – Cancer Genetics reported today that its third quarter revenues were up 68 percent year over year.

The oncology-focused clinical services firm reported total Q3 revenues of $6.8 million compared to $4 million in Q3 2015. 

The firm reported a 204 percent increase in clinical services test volume to 7,334 tests, driven by an increase in immuno-oncology testing, companion diagnostic testing for PD-L1, and solid tumor profiling.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
19
Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.